Abstract
na
| Original language | English |
|---|---|
| Pages (from-to) | 1105-1107 |
| Number of pages | 3 |
| Journal | Neurological Sciences |
| Volume | 44 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2023 |
All Science Journal Classification (ASJC) codes
- Dermatology
- Clinical Neurology
- Psychiatry and Mental health
Keywords
- Antibodies
- Autoantibodies
- Humans
- Interleukin Inhibitors
- Interleukin-17
- Letter
- Muscles
- Myasthenia Gravis
- adult
- antibody
- antibody blood level
- antibody detection
- antibody titer
- autoantibody
- case report
- clinical article
- cyclosporine
- drug dose reduction
- drug tolerability
- drug withdrawal
- gastrointestinal symptom
- human
- interleukin 17
- male
- muscle
- muscle specific kinase
- myasthenia gravis
- neurologic examination
- phosphotransferase
- prednisone
- psoriasis vulgaris
- pyridostigmine
- secukinumab
- single fiber electromyography
- steroid therapy
- treatment interruption
- unclassified drug
Fingerprint
Dive into the research topics of 'Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver